Quality indicators for cervical cancer care in Japan

Tomone Watanabe, Mikio Mikami, Hidetaka Katabuchi, Shingo Kato, Masanori Kaneuchi, Masahiro Takahashi, Hidekatsu Nakai, Satoru Nagase, Hitoshi Niikura, Masaki Mandai, Yasuyuki Hirashima, Hiroyuki Yanai, Wataru Yamagami, Satoru Kamitani, Takahiro Higashi

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to assess adherence to standard-of-care as an index of the quality of care for cervical cancer in Japan.

METHODS: A panel of clinical experts devised the QIs using a modified Delphi method. Adherence to each QI was evaluated using data from a hospital-based cancer registry of patients diagnosed in 2013, and linked with insurance claims data, between October 1, 2012, and December 31, 2014. All patients who received first-line treatment at the participating facility were included. The QI scores were communicated to participating hospitals, and additional data about the reasons for non-adherence were collected.

RESULTS: In total, 297 hospitals participated, and the care provided to 15,163 cervical cancer patients was examined using 10 measurable QIs. The adherence rate ranged from 50.0% for 'cystoscope or proctoscope for stage IVA' to 98.8% for 'chemotherapy using platinum for stage IVB'. Despite the variation in care, hospitals reported clinically valid reasons for more than half of the non-adherent cases. Clinically valid reasons accounted for 75%, 90.9%, 73.4%, 44.5%, and 88.1% of presented non-adherent cases respectively.

CONCLUSION: Our study revealed variations in pattern of care as well as an adherence to standards-of-care across Japan. Further assessment of the causes of variation and non-adherence can help identify areas where improvements are needed in patient care.

Original languageEnglish
Pages (from-to)e83
JournalJournal of Gynecologic Oncology
Volume29
Issue number6
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Uterine Cervical Neoplasms
Japan
Standard of Care
Proctoscopes
Cystoscopes
Cancer Care Facilities
Quality of Health Care
Platinum
Insurance
Registries
Patient Care
Guidelines
Drug Therapy
Therapeutics

Keywords

  • Guideline Adherence
  • Practice Guideline
  • Quality Indicators
  • Standard of Care
  • Uterine Cervical Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Watanabe, T., Mikami, M., Katabuchi, H., Kato, S., Kaneuchi, M., Takahashi, M., ... Higashi, T. (2018). Quality indicators for cervical cancer care in Japan. Journal of Gynecologic Oncology, 29(6), e83. https://doi.org/10.3802/jgo.2018.29.e83

Quality indicators for cervical cancer care in Japan. / Watanabe, Tomone; Mikami, Mikio; Katabuchi, Hidetaka; Kato, Shingo; Kaneuchi, Masanori; Takahashi, Masahiro; Nakai, Hidekatsu; Nagase, Satoru; Niikura, Hitoshi; Mandai, Masaki; Hirashima, Yasuyuki; Yanai, Hiroyuki; Yamagami, Wataru; Kamitani, Satoru; Higashi, Takahiro.

In: Journal of Gynecologic Oncology, Vol. 29, No. 6, 01.11.2018, p. e83.

Research output: Contribution to journalArticle

Watanabe, T, Mikami, M, Katabuchi, H, Kato, S, Kaneuchi, M, Takahashi, M, Nakai, H, Nagase, S, Niikura, H, Mandai, M, Hirashima, Y, Yanai, H, Yamagami, W, Kamitani, S & Higashi, T 2018, 'Quality indicators for cervical cancer care in Japan', Journal of Gynecologic Oncology, vol. 29, no. 6, pp. e83. https://doi.org/10.3802/jgo.2018.29.e83
Watanabe T, Mikami M, Katabuchi H, Kato S, Kaneuchi M, Takahashi M et al. Quality indicators for cervical cancer care in Japan. Journal of Gynecologic Oncology. 2018 Nov 1;29(6):e83. https://doi.org/10.3802/jgo.2018.29.e83
Watanabe, Tomone ; Mikami, Mikio ; Katabuchi, Hidetaka ; Kato, Shingo ; Kaneuchi, Masanori ; Takahashi, Masahiro ; Nakai, Hidekatsu ; Nagase, Satoru ; Niikura, Hitoshi ; Mandai, Masaki ; Hirashima, Yasuyuki ; Yanai, Hiroyuki ; Yamagami, Wataru ; Kamitani, Satoru ; Higashi, Takahiro. / Quality indicators for cervical cancer care in Japan. In: Journal of Gynecologic Oncology. 2018 ; Vol. 29, No. 6. pp. e83.
@article{dd2ffad00b764f4187ab1c751ac0387f,
title = "Quality indicators for cervical cancer care in Japan",
abstract = "OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to assess adherence to standard-of-care as an index of the quality of care for cervical cancer in Japan.METHODS: A panel of clinical experts devised the QIs using a modified Delphi method. Adherence to each QI was evaluated using data from a hospital-based cancer registry of patients diagnosed in 2013, and linked with insurance claims data, between October 1, 2012, and December 31, 2014. All patients who received first-line treatment at the participating facility were included. The QI scores were communicated to participating hospitals, and additional data about the reasons for non-adherence were collected.RESULTS: In total, 297 hospitals participated, and the care provided to 15,163 cervical cancer patients was examined using 10 measurable QIs. The adherence rate ranged from 50.0{\%} for 'cystoscope or proctoscope for stage IVA' to 98.8{\%} for 'chemotherapy using platinum for stage IVB'. Despite the variation in care, hospitals reported clinically valid reasons for more than half of the non-adherent cases. Clinically valid reasons accounted for 75{\%}, 90.9{\%}, 73.4{\%}, 44.5{\%}, and 88.1{\%} of presented non-adherent cases respectively.CONCLUSION: Our study revealed variations in pattern of care as well as an adherence to standards-of-care across Japan. Further assessment of the causes of variation and non-adherence can help identify areas where improvements are needed in patient care.",
keywords = "Guideline Adherence, Practice Guideline, Quality Indicators, Standard of Care, Uterine Cervical Neoplasms",
author = "Tomone Watanabe and Mikio Mikami and Hidetaka Katabuchi and Shingo Kato and Masanori Kaneuchi and Masahiro Takahashi and Hidekatsu Nakai and Satoru Nagase and Hitoshi Niikura and Masaki Mandai and Yasuyuki Hirashima and Hiroyuki Yanai and Wataru Yamagami and Satoru Kamitani and Takahiro Higashi",
year = "2018",
month = "11",
day = "1",
doi = "10.3802/jgo.2018.29.e83",
language = "English",
volume = "29",
pages = "e83",
journal = "Journal of Gynecologic Oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "6",

}

TY - JOUR

T1 - Quality indicators for cervical cancer care in Japan

AU - Watanabe, Tomone

AU - Mikami, Mikio

AU - Katabuchi, Hidetaka

AU - Kato, Shingo

AU - Kaneuchi, Masanori

AU - Takahashi, Masahiro

AU - Nakai, Hidekatsu

AU - Nagase, Satoru

AU - Niikura, Hitoshi

AU - Mandai, Masaki

AU - Hirashima, Yasuyuki

AU - Yanai, Hiroyuki

AU - Yamagami, Wataru

AU - Kamitani, Satoru

AU - Higashi, Takahiro

PY - 2018/11/1

Y1 - 2018/11/1

N2 - OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to assess adherence to standard-of-care as an index of the quality of care for cervical cancer in Japan.METHODS: A panel of clinical experts devised the QIs using a modified Delphi method. Adherence to each QI was evaluated using data from a hospital-based cancer registry of patients diagnosed in 2013, and linked with insurance claims data, between October 1, 2012, and December 31, 2014. All patients who received first-line treatment at the participating facility were included. The QI scores were communicated to participating hospitals, and additional data about the reasons for non-adherence were collected.RESULTS: In total, 297 hospitals participated, and the care provided to 15,163 cervical cancer patients was examined using 10 measurable QIs. The adherence rate ranged from 50.0% for 'cystoscope or proctoscope for stage IVA' to 98.8% for 'chemotherapy using platinum for stage IVB'. Despite the variation in care, hospitals reported clinically valid reasons for more than half of the non-adherent cases. Clinically valid reasons accounted for 75%, 90.9%, 73.4%, 44.5%, and 88.1% of presented non-adherent cases respectively.CONCLUSION: Our study revealed variations in pattern of care as well as an adherence to standards-of-care across Japan. Further assessment of the causes of variation and non-adherence can help identify areas where improvements are needed in patient care.

AB - OBJECTIVE: We aimed to propose a set of quality indicators (QIs) based on the clinical guidelines for cervical cancer treatment published by The Japan Society of Gynecologic Oncology, and to assess adherence to standard-of-care as an index of the quality of care for cervical cancer in Japan.METHODS: A panel of clinical experts devised the QIs using a modified Delphi method. Adherence to each QI was evaluated using data from a hospital-based cancer registry of patients diagnosed in 2013, and linked with insurance claims data, between October 1, 2012, and December 31, 2014. All patients who received first-line treatment at the participating facility were included. The QI scores were communicated to participating hospitals, and additional data about the reasons for non-adherence were collected.RESULTS: In total, 297 hospitals participated, and the care provided to 15,163 cervical cancer patients was examined using 10 measurable QIs. The adherence rate ranged from 50.0% for 'cystoscope or proctoscope for stage IVA' to 98.8% for 'chemotherapy using platinum for stage IVB'. Despite the variation in care, hospitals reported clinically valid reasons for more than half of the non-adherent cases. Clinically valid reasons accounted for 75%, 90.9%, 73.4%, 44.5%, and 88.1% of presented non-adherent cases respectively.CONCLUSION: Our study revealed variations in pattern of care as well as an adherence to standards-of-care across Japan. Further assessment of the causes of variation and non-adherence can help identify areas where improvements are needed in patient care.

KW - Guideline Adherence

KW - Practice Guideline

KW - Quality Indicators

KW - Standard of Care

KW - Uterine Cervical Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85055076663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055076663&partnerID=8YFLogxK

U2 - 10.3802/jgo.2018.29.e83

DO - 10.3802/jgo.2018.29.e83

M3 - Article

VL - 29

SP - e83

JO - Journal of Gynecologic Oncology

JF - Journal of Gynecologic Oncology

SN - 2005-0380

IS - 6

ER -